FMII
AZN icon

Farmers & Merchants Investments Inc’s AstraZeneca AZN Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.5K Sell
500
-53
-10% -$9.97K ﹤0.01% 391
2026
Q1 		$107K Hold
553
– – ﹤0.01% 364
2025
Q4 		$102K Hold
553
– – ﹤0.01% 359
2025
Q3 		$84.9K Hold
553
– – ﹤0.01% 381
2025
Q2 		$77.3K Hold
553
– – ﹤0.01% 391
2025
Q1 		$81.3K Buy
553
+53
+11% +$7.67K ﹤0.01% 388
2024
Q4 		$65.5K Hold
500
– – ﹤0.01% 417
2024
Q3 		$77.9K Buy
+500
New +$80.7K ﹤0.01% 408
2023
Q2 		– Sell
-15
Closed -$2.01K – 1765
2023
Q1 		$2.01K Buy
+15
New +$2.02K ﹤0.01% 1029
2022
Q3 		– Sell
-239
Closed -$32K – 1563
2022
Q2 		$32K Buy
239
+38
+19% +$4.99K ﹤0.01% 480
2022
Q1 		$27K Hold
201
– – ﹤0.01% 526
2021
Q4 		$23K Buy
+201
New +$23.7K ﹤0.01% 561
2017
Q1 		– Sell
-320
Closed -$17K – 735
2016
Q4 		$17K Sell
320
-41
-11% -$2.33K ﹤0.01% 449
2016
Q3 		$24K Sell
361
-1,939
-84% -$127K ﹤0.01% 355
2016
Q2 		$139K Sell
2,300
-50
-2% -$2.9K 0.02% 218
2016
Q1 		$132K Sell
2,350
-100
-4% -$6.01K 0.02% 219
2015
Q4 		$166K Sell
2,450
-50
-2% -$3.28K 0.02% 220
2015
Q3 		$159K Hold
2,500
– – 0.02% 214
2015
Q2 		$159K Sell
2,500
-400
-14% -$27.4K 0.02% 217
2015
Q1 		$198K Sell
2,900
-500
-15% -$34.7K 0.02% 203
2014
Q4 		$239K Sell
3,400
-200
-6% -$14.3K 0.03% 185
2014
Q3 		$257K Sell
3,600
-400
-10% -$29.3K 0.03% 182
2014
Q2 		$297K Sell
4,000
-743
-16% -$53.7K 0.04% 175
2014
Q1 		$308K Sell
4,743
-150
-3% -$9.69K 0.04% 175
2013
Q4 		$290K Sell
4,893
-500
-9% -$27.2K 0.04% 179
2013
Q3 		$280K Buy
5,393
+43
+0.8% +$2.16K 0.04% 179
2013
Q2 		$253K Buy
+5,350
New +$272K 0.04% 189

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Farmers & Merchants Investments Inc's AZN Position: Q2 2026 in Review

Farmers & Merchants Investments Inc reduced its AstraZeneca (AZN) stake by 9.6% in Q2 2026, selling an estimated $9.97K and leaving 500 shares worth $93.5K. The position accounts for ﹤0.01% of the portfolio, ranked #391.

Farmers & Merchants Investments Inc first reported a position in AZN in Q2 2013 and has held it in 27 quarters since. The position peaked at $308K in Q1 2014. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Farmers & Merchants Investments Inc held 500 shares of AstraZeneca worth $93.5K as of Q2 2026.
  • Farmers & Merchants Investments Inc sold 53 AstraZeneca shares in Q2 2026, an estimated $9.97K.
  • AstraZeneca made up ﹤0.01% of Farmers & Merchants Investments Inc's portfolio in Q2 2026, its #391 holding.
  • Farmers & Merchants Investments Inc first reported a position in AstraZeneca in Q2 2013 and has held it in 27 quarters since.
  • Farmers & Merchants Investments Inc's AstraZeneca position peaked at $308K in Q1 2014.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.